Melissa M. Tomkiel insider trades: Strata Critical Medical (SRTA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Melissa reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | SRTA | ↓ Sell | 29,730 | $5.87 | $175K | Direct | Jun 10, 2026 (2d) |
| Aug 4, 2025 | BLDE | ↓ Sell | 47,995 | $4.94 | $237K | Direct | Aug 5, 2025 (1d) |
| Jun 9, 2025 | BLDE | ↓ Sell | 100,000 | $4.08 | $408K | Direct | Jun 11, 2025 (2d) |
| Dec 9, 2024 | BLDE | ↓ Sell | 22,486 | $5.01 | $113K | Direct | Dec 11, 2024 (2d) |
| Nov 29, 2024 | BLDE | ↓ Sell | 111,377 | $4.50 | $502K | Direct | Nov 29, 2024 (0d) |
| Nov 12, 2024 | BLDE | ↓ Sell | 44,621 | $3.40 | $152K | Direct | Nov 13, 2024 (1d) |
| Apr 3, 2024 | BLDE | ↓ Sell | 22,836 | $3.28 | $75K | Direct | Apr 5, 2024 (2d) |
| Mar 14, 2024 | BLDE | ↓ Sell | 51,825 | $2.70 | $140K | Direct | Mar 15, 2024 (1d) |
| Dec 15, 2023 | BLDE | ↓ Sell | 35,969 | $3.11 | $112K | Direct | Dec 15, 2023 (0d) |
| Oct 6, 2023 | BLDE | ↓ Sell | 37,656 | $2.44 | $92K | Direct | Oct 6, 2023 (0d) |
| Jul 10, 2023 | BLDE | ↓ Sell | 91,080 | $3.82 | $348K | Direct | Jul 10, 2023 (0d) |
| Apr 10, 2023 | BLDE | ↓ Sell | 39,951 | $2.90 | $116K | Direct | Apr 11, 2023 (1d) |
| Jan 9, 2023 | BLDE | ↓ Sell | 5,139 | $3.47 | $18K | Direct | Jan 12, 2023 (3d) |
| Oct 6, 2022 | BLDE | ↓ Sell | 4,366 | $3.97 | $17K | Direct | Oct 11, 2022 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other SRTA insiders
Open-market trades in the last 12 months
About Melissa M. Tomkiel's insider trades
Melissa M. Tomkiel is Co-CEO and General Counsel at Strata Critical Medical (SRTA). Since Oct 6, 2022, Melissa has reported no open-market purchases and 14 sales worth $2.5M on SEC Form 4. In the last 12 months: 1 sale ($175K).
Their filings also include option exercises (20 filings), shares withheld for taxes (16 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.